Artivila

Overview

Kehui Zhiyao is an AI-driven innovative drug developer

Funding · 1

Amounts as reported; USD estimates shown only when they match

Listed 1 funding record. Latest funding: RMB 100M (Pre-Series A), Mar 31, 2022.

Annual trendUnit: USD

Date	Amount	Investors	Sources
Mar 31, 2022	RMB 100M ≈ $14.3M · Pre-Series A	健壹资本, 博普资产, 山行资本, 弘晖基金, 无锡金投, 泽盛资本, 锐革实业	No source link
Evidence No source brief is attached to this record. Sources · 0 No original source link on this record. UniqueBase news brief ↗Full English brief and original title Investors 健壹资本, 博普资产, 山行资本, 弘晖基金, 无锡金投, 泽盛资本, 锐革实业

Select ▸ on a row to see its source brief and links.

Valuation · 1

Amounts as reported; USD estimates shown only when they match

Listed 1 valuation record.

Annual trendUnit: USD

No chartable valuation estimates yet.

1 listed record lack a clear date or positive USD estimate for the chart.

Date	Amount	Investors	Sources
Mar 31, 2022	— · Pre-Series A	健壹资本, 博普资产, 山行资本, 弘晖基金, 无锡金投, 泽盛资本, 锐革实业	No source link
Evidence No source brief is attached to this record. Sources · 0 No original source link on this record. UniqueBase news brief ↗Full English brief and original title Investors 健壹资本, 博普资产, 山行资本, 弘晖基金, 无锡金投, 泽盛资本, 锐革实业

Select ▸ on a row to see its source brief and links.

Revenue

Amounts as reported; USD estimates shown only when they match

No revenue records are listed yet.

No revenue rows to list.

Sources · 0

English text is maintained separately from the original record. Consult the original source before citing a fact.

No source links are available for this profile.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

人工智能驱动创新药物研发商科辉智药是一家人工智能驱动创新药物研发商